LRG Webcast Series: Updates on the Temozolomide Trial
Rescheduled - Dr. Jason Sicklick of Moores Cancer Center at UCSD will present a webcast detailing the Phase II study of Temozolomide in advanced SDH-mutant/deficient GIST, a new study available to patients with SDH-deficient GIST.